Literature DB >> 3143028

Dot enzyme-linked immunosorbent assay (dot ELISA) for antibodies to Encephalitozoon cuniculi.

C Beckwith1, N Peterson, J J Liu, J A Shadduck.   

Abstract

A dot-ELISA procedure was developed to detect antibodies against Encephalitozoon cuniculi. Sera from 84 rabbits, 22 dogs, 18 squirrel monkeys and 200 mice were tested by dot-ELISA and most also were tested by immunofluorescence. Comparison of the two tests showed that there was excellent agreement of the results (Kappa values greater than or equal to 0.74) in all four species. Dot-ELISA is a simple, quantitative, rapid alternative to immunofluorescence when large numbers of serum samples must be evaluated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143028

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  6 in total

1.  Generalized encephalitozoonosis in a Jersey wooly rabbit.

Authors:  R Nast; D M Middleton; C L Wheler
Journal:  Can Vet J       Date:  1996-05       Impact factor: 1.008

Review 2.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

3.  Enteric infection with an obligate intracellular parasite, Encephalitozoon cuniculi, in an experimental model.

Authors:  V Wicher; R E Baughn; C Fuentealba; J A Shadduck; F Abbruscato; K Wicher
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

Review 4.  Therapeutic targets for the treatment of microsporidiosis in humans.

Authors:  Bing Han; Louis M Weiss
Journal:  Expert Opin Ther Targets       Date:  2018-11-01       Impact factor: 6.902

Review 5.  Microsporidia and human infections.

Authors:  J A Shadduck; E Greeley
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

6.  An indirect ELISA for detection of Encephalitozoon cuniculi infection in farmed blue foxes (Alopex lagopus).

Authors:  J Akerstedt
Journal:  Acta Vet Scand       Date:  2002       Impact factor: 1.695

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.